INNOGENE Co.,Ltd. (KOSDAQ:344860)
South Korea · Delayed Price · Currency is KRW 1,299.00
-78.00 (-5.66%)
At close: Oct 2, 2026
INNOGENE Market Cap
INNOGENE has a market cap or net worth of 18.74 billion as of October 2, 2026. Its market cap has decreased by -9.25% in one year.
Market Cap
18.74B
Enterprise Value
11.67B
Revenue
11.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,299.00
ChartMarket Cap Chart
Since April 27, 2020, INNOGENE's market cap has increased from 9.45B to 18.74B, an increase of 98.42%. That is a compound annual growth rate of 11.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 18.74B | -16.41% |
| Dec 30, 2025 | 22.42B | 25.86% |
| Dec 30, 2024 | 17.82B | -45.95% |
| Dec 28, 2023 | 32.96B | -19.53% |
| Dec 29, 2022 | 40.96B | -2.00% |
| Dec 30, 2021 | 41.80B | 1,851.22% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Newtree | 32.37B |
| HuM&C | 31.39B |
| TS Trillion | 29.18B |
| KODI CO., LTD | 26.94B |
| Csa Cosmic | 24.38B |
| INSAN | 21.00B |
| SR biotek | 19.96B |
| Nord Mason | 19.41B |